Metagenomi, Inc. (MGX)
NASDAQ · Healthcare
Metagenomi, Inc. Shareholder Equity 2023–2025
Metagenomi, Inc. annual/quarterly shareholder equity history from 2023 to 2025. Shareholder equity represents the net worth of a company, calculated as total assets minus total liabilities.
- Metagenomi, Inc. shareholder equity for the quarter ending December 31, 2025 were 158.6M, a 32.47% decrease year-over-year.
- Metagenomi, Inc. shareholder equity for 2025 were 158.6M, a 32.47% decrease from 2024.
- Metagenomi, Inc. shareholder equity for 2024 were 234.9M, a 273.22% decrease from 2023.
- Metagenomi, Inc. shareholder equity for 2023 were -135.6M.
Shareholder Equity
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
| Metagenomi, Inc. Annual Shareholder Equity (Millions of US $) | |
|---|---|
| 2025 | $159 |
| 2024 | $235 |
| 2023 | $-136 |
| Metagenomi, Inc. Quarterly Shareholder Equity (Millions of US $) | |
|---|---|
| 2025-12-31 | $159 |
| 2024-12-31 | $235 |
| 2023-12-31 | $-136 |
Metagenomi, Inc. Shareholder Equity — FAQ
Metagenomi, Inc. (MGX) shareholder equity over the last 3 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see MGX's shareholder equity history?
The chart and table above show Metagenomi, Inc.'s shareholder equity by year and by quarter, including the growth rate.